[go: up one dir, main page]

UY24561A1 - Analogos de la vitamina d3 - Google Patents

Analogos de la vitamina d3

Info

Publication number
UY24561A1
UY24561A1 UY24561A UY24561A UY24561A1 UY 24561 A1 UY24561 A1 UY 24561A1 UY 24561 A UY24561 A UY 24561A UY 24561 A UY24561 A UY 24561A UY 24561 A1 UY24561 A1 UY 24561A1
Authority
UY
Uruguay
Prior art keywords
analogs
vitamin
hydroxyl
fluorine
halogen
Prior art date
Application number
UY24561A
Other languages
English (en)
Inventor
Batcho Bryce Henness Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY24561A1 publication Critical patent/UY24561A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de la fórmula (I) en donde R es hidrógeno, fluor, o hidroxilo, alquino inferior o halógeno, X es =CH2 o cuando R es hidroxilo, X es (H,H) o =CH2 y A es (I).
UY24561A 1996-05-23 1997-05-22 Analogos de la vitamina d3 UY24561A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1818696P 1996-05-23 1996-05-23
US1815396P 1996-05-23 1996-05-23
US3990097P 1997-03-19 1997-03-19

Publications (1)

Publication Number Publication Date
UY24561A1 true UY24561A1 (es) 2000-12-29

Family

ID=27360973

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24561A UY24561A1 (es) 1996-05-23 1997-05-22 Analogos de la vitamina d3

Country Status (29)

Country Link
EP (2) EP0808833B1 (es)
JP (1) JP2859247B2 (es)
KR (1) KR100783856B1 (es)
CN (1) CN1176072C (es)
AR (1) AR007241A1 (es)
AT (1) ATE277008T1 (es)
AU (1) AU723929B2 (es)
BR (1) BR9703384A (es)
CA (1) CA2205275C (es)
CO (1) CO4950531A1 (es)
CZ (1) CZ157897A3 (es)
DE (1) DE69730774T2 (es)
DK (1) DK0808833T3 (es)
ES (1) ES2227635T3 (es)
HR (1) HRP970273A2 (es)
HU (1) HUP9700926A3 (es)
IL (1) IL120843A0 (es)
MA (1) MA24251A1 (es)
NO (1) NO972304L (es)
NZ (1) NZ314839A (es)
PE (1) PE70198A1 (es)
PL (1) PL320132A1 (es)
PT (1) PT808833E (es)
SG (1) SG70009A1 (es)
TR (1) TR199700415A2 (es)
TW (1) TW445252B (es)
UY (1) UY24561A1 (es)
YU (1) YU20197A (es)
ZA (1) ZA974336B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
JP2002515898A (ja) * 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
ATE312087T1 (de) * 1997-05-16 2005-12-15 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
EP0957098A1 (en) * 1998-05-14 1999-11-17 F. Hoffmann-La Roche Ag Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
BR122012030847B1 (pt) * 1999-04-23 2021-07-06 Leo Pharma A/S Composição farmacêutica não aquosa para uso dermatológico, e, uso da mesma
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
WO2001040177A2 (en) * 1999-12-02 2001-06-07 Women And Infants Hospital Esters of vitamin d3 and uses thereof
CH698144B1 (fr) * 2003-09-24 2009-05-29 Bioxell Spa Analogue de la vitamine D3
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
SG110107A1 (en) 2003-09-24 2005-04-28 Bioxell Spa Compound and use in treatment
AU2005216651A1 (en) 2004-03-01 2005-09-09 Bioxell Spa Treatment of interstitial cystitis with vitamin D compounds
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US8906888B2 (en) * 2005-04-25 2014-12-09 Cytochroma Inc. Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3
WO2007022433A2 (en) * 2005-08-18 2007-02-22 Bioxell S.P.A. SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
WO2008091686A2 (en) * 2007-01-25 2008-07-31 Bioxell S.P.A. SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
JP5480131B2 (ja) 2007-05-30 2014-04-23 シトクロマ インコーポレイテッド ホスフィンオキシドビタミンｄ前駆物質の製造方法
ES2366077B2 (es) * 2010-03-30 2012-06-25 Universidade De Vigo Compuestos quirales, procedimientos de obtención y uso.
JP5738307B2 (ja) * 2010-10-25 2015-06-24 帝人ファーマ株式会社 ２３−イン−ビタミンｄ３誘導体
US10044913B2 (en) * 2012-11-07 2018-08-07 Vid Scale, Inc. Temporal filter for denoising a high dynamic range video
CN105348164B (zh) * 2015-10-29 2017-03-29 无锡福祈制药有限公司 一种1α‑羟基维生素D2的制备方法
CN106748942B (zh) * 2016-11-28 2018-06-29 无锡福祈制药有限公司 度骨化醇类似物wxfq-65及其合成方法
ES2731558B2 (es) * 2018-05-15 2020-03-18 Univ Santiago Compostela Compuestos de interés farmacéutico
CN109738252B (zh) * 2019-01-23 2021-03-09 深圳天辰医疗科技有限公司 25-羟基-维生素d解离液
CN109696435B (zh) * 2019-01-25 2021-03-09 深圳天辰医疗科技有限公司 维生素d的测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3228488B2 (ja) * 1993-12-24 2001-11-12 株式会社クラレ ２０−エピステロイド誘導体およびその製造方法

Also Published As

Publication number Publication date
NO972304D0 (no) 1997-05-21
AU2357797A (en) 1997-11-27
SG70009A1 (en) 2000-01-25
CO4950531A1 (es) 2000-09-01
TW445252B (en) 2001-07-11
AR007241A1 (es) 1999-10-27
DK0808833T3 (da) 2005-01-31
MX9703774A (es) 1998-06-30
HU9700926D0 (en) 1997-07-28
JPH1045713A (ja) 1998-02-17
DE69730774T2 (de) 2005-09-29
IL120843A0 (en) 1997-09-30
ES2227635T3 (es) 2005-04-01
ATE277008T1 (de) 2004-10-15
CA2205275C (en) 2007-04-03
TR199700415A3 (tr) 1997-12-21
DE69730774D1 (de) 2004-10-28
PL320132A1 (en) 1997-11-24
HUP9700926A2 (hu) 1998-01-28
TR199700415A2 (xx) 1997-12-21
EP1464640A2 (en) 2004-10-06
MA24251A1 (fr) 1998-04-01
JP2859247B2 (ja) 1999-02-17
EP1464640A3 (en) 2005-01-12
EP0808833A3 (en) 1998-11-25
AU723929B2 (en) 2000-09-07
ZA974336B (en) 1997-11-24
PE70198A1 (es) 1998-11-26
CN1175573A (zh) 1998-03-11
HRP970273A2 (en) 1998-04-30
BR9703384A (pt) 1998-09-15
CZ157897A3 (en) 1997-12-17
KR100783856B1 (ko) 2008-05-09
EP0808833B1 (en) 2004-09-22
CN1176072C (zh) 2004-11-17
YU20197A (sh) 1999-09-27
NO972304L (no) 1997-11-24
PT808833E (pt) 2004-11-30
NZ314839A (en) 2000-01-28
CA2205275A1 (en) 1997-11-23
KR970074765A (ko) 1997-12-10
EP0808833A2 (en) 1997-11-26
HUP9700926A3 (en) 1999-05-28

Similar Documents

Publication Publication Date Title
UY24561A1 (es) Analogos de la vitamina d3
YU47204B (sh) Derivati didehidro-vitamina d3
AU1642795A (en) Substituted pyridylpyrazoles
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
HU9301361D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
NO962497L (no) Fluoridert micellært kasein
TW374762B (en) Fluorinated vitamin D3 analogs
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DE69304279D1 (de) Fluorierte Analoge Vitamins D3
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
ES2150564T3 (es) Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno.
TR199900504T2 (xx) Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi
ATE152624T1 (de) Verwendung von prostacyclin-analoga gegen metastasen
DE3560017D1 (en) Tetraene, its preparation and its use
ES2074182T3 (es) 2-amino-(fluoralcoxi-pirimidinas) y procedimiento para su obtencion.
ECSP972130A (es) Analogos de vitamina d3 - fluorinados
MX9707832A (es) 1-fenil-3-pirazolcarboxilamidas que actuan sobre los receptores de neurotensina.
ES2151615T3 (es) Procedimiento para la obtencion de pirazoles.
MX9703775A (es) Analogos de vitamina d3 fluorados.
UY24326A1 (es) Nuevas piperidinas.
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
GT199900060A (es) Polimorfos de un monoclorhidrato de pirazina cristalino y sus composiciones farmacèuticas.
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.